CN1424067A - Medicines for treating cancers and tumours - Google Patents
Medicines for treating cancers and tumours Download PDFInfo
- Publication number
- CN1424067A CN1424067A CN02128114A CN02128114A CN1424067A CN 1424067 A CN1424067 A CN 1424067A CN 02128114 A CN02128114 A CN 02128114A CN 02128114 A CN02128114 A CN 02128114A CN 1424067 A CN1424067 A CN 1424067A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- tumor
- rhizoma
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating cancers and tumors is prepared from 17 Chinese-medicinal materials including ginseng, Chinese angelica root, Chuan-xiong rhizome, peach kernel, safflower, etc. Its advantages are sure curative effect and no toxic by-effect.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of cancer and tumor, specifically is the treatment cancer made of raw material and the medicine of tumor with the Chinese herbal medicine.
Background technology
Cancer is the medical science difficulty that the countries in the world medical expert is capturing.Up to the present, also there is not a kind of specially good effect good medicine for the treatment of cancer and tumor.According to theory of Chinese medical science, the reason that cancer generates is the imbalance of YIN and YANG because of patient self, QI and blood is unbalance, causes due to self resistivity descends, and energy and blood of human body stagnates and becomes prompt tumor, promptly form canceration, modern Chinese medicine circle is all making great efforts exploring the various approach for the treatment of cancer.
Present Therapeutic Method be to early, mid-term cancer and tumor patient carry out operative treatment, chemotherapy, radiotherapy, the bonded complex treatment measure of Chinese medicine and western medicine, although obtained certain curative effect, it also only is the effect of playing relief of symptoms, for the late malignant tumour patient, lack especially effectively Therapeutic Method.Anticancer Western medicine commonly used has interferon, interleukin, 5-flurouracil etc., and the effect that these medicines have is undesirable, and the side effect that has is too big, brings many miseries to the patient.Though now some anticancer antineoplastic Chinese patent medicines are arranged also, its prescription is different, still there is not medicine with same materials compatibility of the present invention.
Summary of the invention
The object of the present invention is to provide a kind of medicine that can treat various cancers and tumor, cancer patient is palliated the agonizing sufferings, improve symptom, tumor is dwindled or generate alleviation, prolong life span, improve the purpose of life quality thereby reach.
Solution of the present invention is to the pathogeny of generation, development and the transfer of cancer and tumor and Therapeutic Principle's understanding according to China's traditional medicine, gain knowledge in conjunction with modern pharmacology, the applicant groping and summing up through what reach surplus in the of 30 year, from motherland's medical treasure-house, filter out the development (recurrence, transfer) that has no side effect, can suppress tumor, safeguard the allomeric function of body, and can activating blood circulation to dissipate blood stasis, the pure raw material of Chinese medicine composition of prescription of regulating QI to relieve pain, hard masses softening and resolving, heat-clearing and toxic substances removing, strengthening the body resistance, develop anticancer, antitumor medicament of the present invention.
Medicine of the present invention is (consumption the is a weight portion) medicament that comprises that the following raw materials according component is made:
Radix Ginseng 11-19 Radix Angelicae Sinensis 11-19 Rhizoma Chuanxiong 7-13
Semen Persicae 7-13 Flos Carthami 7-13 Radix Salviae Miltiorrhizae 11-19
Lignum Sappan 11-19 blood leads to 11-19 Radix Dipsaci 11-19
Radix curcumae 7-13 Herba Taraxaci 16-24 rhizoma sparganic 7-13
Rhizoma Curcumae 7-13 Thallus Laminariae (Thallus Eckloniae) 16-24 Sargassum 16-24
Radix Notoginseng 3-7 big gun first 7-13 Radix Paeoniae Rubra 7-13.
Formula optimization weight (part) ratio range of preparation medicine of the present invention is:
Radix Ginseng 14-16 Radix Angelicae Sinensis 14-16 Rhizoma Chuanxiong 9-11
Semen Persicae 9-11 Flos Carthami 9-11 Radix Salviae Miltiorrhizae 14-16
Lignum Sappan 14-16 blood leads to 14-16 Radix Dipsaci 14-16
Radix curcumae 9-11 Herba Taraxaci 18-22 rhizoma sparganic 9-11
Rhizoma Curcumae 9-11 Thallus Laminariae (Thallus Eckloniae) 18-22 Sargassum 18-22
Radix Notoginseng 4-6 big gun first 9-11 Radix Paeoniae Rubra 9-11.
The optimum weight of medicine of the present invention (part) proportioning is:
Radix Ginseng 15 Radix Angelicae Sinensis 15 Rhizoma Chuanxiongs 10
Semen Persicae 10 Flos Carthamis 10 Radix Salviae Miltiorrhizaes 15
Lignum Sappan 15 blood lead to 15 Radix Dipsacis 15
Radix curcumae 10 Herba Taraxacis 20 rhizoma sparganic 10
Rhizoma Curcumae 10 Thallus Laminariae (Thallus Eckloniae)s 20 Sargassums 20
Radix Notoginseng 5 Squama Maniss 10 Radix Paeoniae Rubra 10.
Described medicine material also comprises Rhizoma Corydalis 7-13 part.
Described medicine material also comprises Spica Prunellae, Herba Violae, Radix Achyranthis Bidentatae, Radix Isatidis, Bal(n)phyllia sp., Gekko Swinhonis, and is wherein at least a, and the weight of each raw material (part) ratio range is:
Spica Prunellae 12-17 Herba Violae 12-17 Radix Achyranthis Bidentatae 8-10
Radix Isatidis 8-12 goose pipe 12-17 Gekko Swinhonis 12-17.
Described big gun first is the raw material of Chinese medicine of Squama Manis after parch.
Described medicament is a said dosage form on any pharmaceutics.As water preparation, capsule, tablet, pill, powder, unguentum etc.
Described dosage form is to be prepared from conventional pharmaceutical methods.
The raw material of Chinese medicine scientific composition that the present invention selects for use: ginseng qi-tonifying; Radix Angelicae Sinensis, Rhizoma Chuanxiong promoting blood circulation to restore menstrual flow; The Semen Persicae analgesia is by evil; The Radix Paeoniae Rubra eliminating stagnation is ended bitterly; The Flos Carthami dissipating blood stasis that stimulates the menstrual flow; Radix Salviae Miltiorrhizae regulating menstruation removing blood stasis with potent drugs; The defeated venting QI-blood conditioning of Lignum Sappan; Stasis of blood poison is exclusive all for blood; The corydalis tuber analgesic function is long-term; The radix curcumae resolving depression has siddhi; Herba Taraxaci is separated the cloudy light toxicity of fainting; Rhizoma sparganic, the logical whole body meridian of Rhizoma Curcumae; The specially diffusing carcinoma of Sargassum, Thallus Laminariae (Thallus Eckloniae); The Radix Notoginseng tissue regeneration promoting removes the stasis of blood; The big gun first is led to whole body meridian.Execute the principle of controlling according to differential diagnosis in tcm, on the basis of medicament of the present invention, different onset mechanism at various cancers and tumor is added and subtracted, and can to esophageal carcinoma, gastric cancer, pulmonary carcinoma, hepatocarcinoma, intestinal cancer, uterus carcinoma, cancer of pancreas, lymphatic cancer, leukemia, rhinocarcinoma etc. curative effect preferably be arranged respectively.
Medicine of the present invention has blood circulation promoting and blood stasis dispelling, the eliminating stagnation of stimulating the menstrual flow removing blood stasis tissue regeneration promoting, the softening the hard mass that stimulates the menstrual flow, improve immunologic function, have no side effect, can fit various cancer patients takes, make the doing well,improving of tumour patient, tumor is progressively dwindled and is disappeared, and can suppress neoplasm metastasis, strengthen patient's immunity of organisms, improve the survival rate of tumor patient.
Medicine of the present invention passes through function of spleen and stomach regulating, to protect the foundation of acquired constitution, the resistance against diseases of enhancing body, in the hope of strengthening vital QI to eliminate pathogenic factors, decapacitation is eliminating evil sends an expedition against outside the local tumor, can also regulate the allomeric function of body, make certain cancers patient's the state of an illness obtain in various degree alleviation and recovery, most cancer patient's symptoms are disappeared unexpectedly; Medicine wide adaptability of the present invention all has curative effect preferably to various cancers and tumor.Medicine of the present invention sees the following form through the clinical practice curative effect:
| Cerebroma | Esophageal carcinoma | Gastric cancer | Pulmonary carcinoma | Tracheocarcinoma | Cancer of biliary duct | Hepatocarcinoma | Uterus carcinoma | ||||||||
| Case load | Effective percentage | Case load | Effective percentage | Case load | Effective percentage | Case load | Effective percentage | Case load | Effective percentage | Case load | Effective percentage | Case load | Effective percentage | Case load | Effective percentage |
| ??15 | ??85％ | ??78 | ???85％ | ??84 | ??90％ | ??74 | ??90％ | ??58 | ??98％ | ??31 | ??92％ | ??27 | ??85％ | ??93 | ??95％ |
| Ovarian tumor | Rectal cancer | Osteocarcinoma | Thyroid carcinoma | Cancer of pancreas | Lymphatic cancer | Breast carcinoma | Rhinocarcinoma | ||||||||
| Case load | Effective percentage | Case load | Effective percentage | Case load | Effective percentage | Case load | Effective percentage | Case load | Effective percentage | Case load | Effective percentage | Case load | Effective percentage | Case load | Effective percentage |
| ??87 | ??95％ | ??25 | ???90％ | ??17 | ??90％ | ??34 | ??90％ | ??45 | ??90％ | ??124 | ??93％ | ??53 | ??90％ | ??37 | ??90％ |
The specific embodiment
Embodiment one
Take by weighing raw material (gram) by following proportioning:
Radix Ginseng 15 Radix Angelicae Sinensis 15 Rhizoma Chuanxiongs 10
Semen Persicae 10 Flos Carthamis 10 Radix Salviae Miltiorrhizaes 15
Lignum Sappan 15 blood lead to 15 radix curcumaes 10
Herba Taraxaci 20 rhizoma sparganic 10 Radix Dipsacis 15
Rhizoma Curcumae 10 Thallus Laminariae (Thallus Eckloniae)s 20 Sargassums 20
Radix Notoginseng 5 big gun first 10 Radix Paeoniae Rubra 10.
The preparation method of this medicine is as follows:
The preparation method of capsule is: the weight proportion according to above-mentioned raw materials is chosen raw material, and raw material is cleaned, dried, and pulverizes, and sieves, sterilization, encapsulated every about 4 grams.
The preparation method of water preparation is: the weight proportion according to above-mentioned raw materials is chosen raw material, raw material is soaked back about 2 hours (or directly decocting), decoct three times: for the first time amount of water be raw material 3-4 doubly, after boiling 30-60 minute (temperature reaches about 120 ℃), filter taking liquid with filter; Medicinal residues after will filtering for the second time add water to powder, boil 15-40 minute after-filtration, taking liquid; For the third time the sediment exclusion of twice medicinal liquid is got rid of the back and merges, boil 20-40 minute (temperature reaches about 100 ℃) again after, medicinal liquid was cooled off quiet clear 3-9 hour, discharge precipitate, taking liquid, sterilization, sealed packaging.About 22 grams of per 100 milliliters of pastilles.
This pharmaceutical dosage form also pharmaceutical methods of available routine is prepared into tablet, pill, powder, unguentum etc.
Embodiment two
Take by weighing raw material (kilogram) by following proportioning:
Radix Ginseng 12 Radix Angelicae Sinensis 12 Rhizoma Chuanxiongs 7
Semen Persicae 7 Flos Carthamis 7 Radix Salviae Miltiorrhizaes 12
Lignum Sappan 12 blood lead to 12 Radix Dipsacis 12
Radix curcumae 7 Herba Taraxacis 16 rhizoma sparganic 7
Rhizoma Curcumae 7 Thallus Laminariae (Thallus Eckloniae)s 16 Sargassums 16
Radix Notoginseng 3 big gun first 7 Radix Paeoniae Rubra 7.
Embodiment three
Take by weighing raw material (kilogram) by following proportioning:
Radix Ginseng 18 Radix Angelicae Sinensis 18 Rhizoma Chuanxiongs 13
Semen Persicae 13 Flos Carthamis 13 Radix Salviae Miltiorrhizaes 18
Lignum Sappan 18 blood lead to 18 Radix Dipsacis 18
Radix curcumae 13 Herba Taraxacis 24 rhizoma sparganic 13
Rhizoma Curcumae 13 Thallus Laminariae (Thallus Eckloniae)s 24 Sargassums 24
Radix Notoginseng 7 big gun first 13 Radix Paeoniae Rubra 13.
Embodiment four
Take by weighing raw material (kilogram) by following proportioning:
Radix Ginseng 16 Radix Angelicae Sinensis 16 Rhizoma Chuanxiongs 11
Semen Persicae 11 Flos Carthamis 11 Radix Salviae Miltiorrhizaes 11
Lignum Sappan 16 blood lead to 16 Radix Dipsacis 16
Radix curcumae 11 Herba Taraxacis 22 rhizoma sparganic 11
Rhizoma Curcumae 11 Thallus Laminariae (Thallus Eckloniae)s 22 Sargassums 22
Radix Notoginseng 6 big gun first 11 Radix Paeoniae Rubra 11.
The foregoing description two, three, four process for preparing medicine are with embodiment one.
In the proportioning raw materials of the foregoing description one to four, can allocate Rhizoma Corydalis 8-12 (the same embodiment of unit of weight) into.
In the proportioning raw materials of the foregoing description one to four, also can allocate Spica Prunellae, Herba Violae, Radix Achyranthis Bidentatae, Radix Isatidis, Bal(n)phyllia sp., Gekko Swinhonis etc. into, wherein one or both or two or more, weight proportion is (the same embodiment of unit of weight): Spica Prunellae 14-16, Herba Violae 14-16, Radix Achyranthis Bidentatae 9-11, Radix Isatidis 9-11, Bal(n)phyllia sp. 9-11, Gekko Swinhonis 14-16.
Medicine of the present invention to early, mid-term tumor patient: water preparation every day three times, each 100 milliliters, one month is a course of treatment; Capsule every day three times, each 4-6 grain, be a course of treatment in January; Medicine of the present invention is to the late malignant tumour patient: water preparation every day three times, each 200 milliliters, one month is a course of treatment; Capsule every day 3 times, each 8, one month is a course of treatment.Patient must guard against edible raw food, preserved egg, tobacco and wine, Fructus Capsici etc. at period in a medicine.
Treatment example one
Yuan Sishen: man, 40 years old, Guang Fu town, Zhongjiang County, Sichuan Province seven people from village, it is sick to do manual work in Chengdu in 85 years, suffers from pulmonary carcinoma through examination in hospital, and tuberculosis pleura, emphysema are arranged, after hospital's treatment in two months, shifted in 87 years for tracheocarcinoma, through taking this medicine capsule, every day three times, each 8, physical recovery is normal after two months, not recurrence so far, and it is the same as before to work.
Treatment example two
Chen Fangying: the woman, 49 years old, people from Jinxiang amassed in the Zhongjiang County, Sichuan Province, suffered from uterus carcinoma through examination in hospital in 92 years, after the underwent operative, secondary radiotherapy, repeatedly chemotherapy is transferred to ovary after several months.This patient body is weak, flatulence pain, lower part of the body distending pain and hemorrhage, and through taking this medicine capsule, every day three times, each 8, physical recovery is normal after taking medicine one month, and recurrence is so far worked with in the past the same.
Treatment example three
Li Minglian: the man, 70 years old, Zhongjiang County, Sichuan Province democracy village people suffered from breast cancer through examination in hospital in 95 years, directly took this medicine capsule in 95 years, and every day three times, each 8, physical recovery is normal after taking medicine 20 days, works with in the past the same, does not recur over 8 years.
Treatment example four
Dai Zeming: the man, 75 years old, Guang Fu people from town, Zhongjiang County, Sichuan Province recurred again behind the operative treatment through examination in hospital trouble cerebroma in 94 years.Took this medicinal agent in 95 years, every day three times, each 100 milliliters, physical recovery is normal behind the one and a half months of taking medicine, and does not recur over 8 years.
Treatment example five
Gu Wanquan: the man, 54 years old, Guang Fu people from town, Zhongjiang County, Sichuan Province, menophania West China examination in hospital was suffered from osteocarcinoma in 2000, recurrence again after hospital undergos surgery treatment.Take this medicine capsule May calendar year 2001, every day three times, each 8, medication treatment is fully recovered after two months, and physical recovery is normal, so far not recurrence.
Treatment example six
Deng Zhizhen: woman, 49 years old, the wide good fortune people in Zhongjiang County, Sichuan Province, 95 years through Mianyang examination in hospital trouble lymphatic cancer, after the underwent operative, transferred to whole body in one month, more than 40 of whole body enclosed mass are taken this medicinal agent in February, 96, every day three times, each 200 milliliters, physical recovery is normal after taking medicine one month, does not recur over 7 years.
Claims (8)
1. medicine for the treatment of cancer and tumor is characterized in that it is the medicament that comprises that the following weight parts proportion raw material is made:
Radix Ginseng 11-19 Radix Angelicae Sinensis 11-19 Rhizoma Chuanxiong 7-13
Semen Persicae 7-13 Flos Carthami 7-13 Radix Salviae Miltiorrhizae 11-19
Lignum Sappan 11-19 blood leads to 11-19 Radix Dipsaci 14-16
Radix curcumae 7-13 Herba Taraxaci 16-24 rhizoma sparganic 7-13
Rhizoma Curcumae 7-13 Thallus Laminariae (Thallus Eckloniae) 16-24 Sargassum 16-24
Radix Notoginseng 3-7 big gun first 7-13 Radix Paeoniae Rubra 7-13.
2. the medicine of treatment cancer according to claim 1 and tumor is characterized in that the weight portion proportioning of each raw material is:
Radix Ginseng 14-16 Radix Angelicae Sinensis 1-4-16 Rhizoma Chuanxiong 9-11
Semen Persicae 9-11 Flos Carthami 9-11 Radix Salviae Miltiorrhizae 14-16
Lignum Sappan 14-16 blood leads to 14-16 Radix Dipsaci 14-16
Radix curcumae 9-11 Herba Taraxaci 18-22 rhizoma sparganic 9-11
Rhizoma Curcumae 9-11 Thallus Laminariae (Thallus Eckloniae) 18-22 Sargassum 18-22
Radix Notoginseng 4-6 big gun first 9-11 Radix Paeoniae Rubra 9-11.
3. the medicine of treatment cancer according to claim 1 and tumor is characterized in that the weight proportion of each raw material is:
Radix Ginseng 15 Radix Angelicae Sinensis 15 Rhizoma Chuanxiongs 10
Semen Persicae 10 Flos Carthamis 10 Radix Salviae Miltiorrhizaes 15
Lignum Sappan 15 blood lead to 15 Radix Dipsacis 15
Radix curcumae 10 Herba Taraxacis 20 rhizoma sparganic 10
Rhizoma Curcumae 10 Thallus Laminariae (Thallus Eckloniae)s 20 Sargassums 20
Radix Notoginseng 5 big gun first 10 Radix Paeoniae Rubra 10.
4. according to the medicine of claim 1 or 2 or 3 described treatment cancers and tumor, it is characterized in that said raw material also comprises Rhizoma Corydalis 7-13 part.
5. according to the medicine of claim 1 or 2 or 3 described treatment cancers and tumor, it is characterized in that said raw material also comprises Spica Prunellae, Herba Violae, Radix Achyranthis Bidentatae, Radix Isatidis, Bal(n)phyllia sp., Gekko Swinhonis, wherein at least a, the weight portion proportioning of each raw material is:
Spica Prunellae 12-17 Herba Violae 12-17 Radix Achyranthis Bidentatae 8-10
Radix Isatidis 8-12 Bal(n)phyllia sp. 12-17 Gekko Swinhonis 12-17.
6. according to the medicine of claim 1 or 2 or 3 described treatment cancers and tumor, it is characterized in that said medicament is a said dosage form on any pharmaceutics.
7. the medicine of treatment cancer according to claim 6 and tumor is characterized in that said medicament is capsule or water preparation or tablet.
8. the medicine of treatment cancer according to claim 7 and tumor is characterized in that said capsule or water preparation or tablet are to be prepared from conventional pharmaceutical methods.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021281149A CN1188153C (en) | 2002-12-26 | 2002-12-26 | Medicines for treating cancers and tumours |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021281149A CN1188153C (en) | 2002-12-26 | 2002-12-26 | Medicines for treating cancers and tumours |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1424067A true CN1424067A (en) | 2003-06-18 |
| CN1188153C CN1188153C (en) | 2005-02-09 |
Family
ID=4745930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021281149A Expired - Fee Related CN1188153C (en) | 2002-12-26 | 2002-12-26 | Medicines for treating cancers and tumours |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1188153C (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103110760A (en) * | 2013-02-27 | 2013-05-22 | 黄克表 | Traditional Chinese medical composition for treating tumor and preparation method thereof |
| CN103908624A (en) * | 2012-12-30 | 2014-07-09 | 刘学堂 | Traditional Chinese medicine composition for treating lymphatic cancer |
| CN104083643A (en) * | 2014-07-24 | 2014-10-08 | 黄武 | Traditional Chinese medicinal composition for treating tumors, early and mid-term cancers and preparation method of traditional Chinese medicinal composition |
| CN104127818A (en) * | 2014-07-24 | 2014-11-05 | 陈桂风 | Traditional Chinese medicinal preparation for treating breast cancer |
| CN104524425A (en) * | 2014-12-05 | 2015-04-22 | 济南高达信息技术有限公司 | Traditional Chinese medicine decoction for treating pancreatic pseudocyst |
| CN105709139A (en) * | 2014-12-25 | 2016-06-29 | 晏合桢 | Medicine for treating tumor and cancer |
| CN109745499A (en) * | 2017-11-02 | 2019-05-14 | 胡志安 | A kind of Chinese herbal medicine pill that treating lympha tumour and preparation method |
-
2002
- 2002-12-26 CN CNB021281149A patent/CN1188153C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103908624A (en) * | 2012-12-30 | 2014-07-09 | 刘学堂 | Traditional Chinese medicine composition for treating lymphatic cancer |
| CN103110760A (en) * | 2013-02-27 | 2013-05-22 | 黄克表 | Traditional Chinese medical composition for treating tumor and preparation method thereof |
| CN103110760B (en) * | 2013-02-27 | 2015-11-25 | 黄克表 | A kind of Chinese medicine composition for the treatment of tumor and preparation method thereof |
| CN104083643A (en) * | 2014-07-24 | 2014-10-08 | 黄武 | Traditional Chinese medicinal composition for treating tumors, early and mid-term cancers and preparation method of traditional Chinese medicinal composition |
| CN104127818A (en) * | 2014-07-24 | 2014-11-05 | 陈桂风 | Traditional Chinese medicinal preparation for treating breast cancer |
| CN104524425A (en) * | 2014-12-05 | 2015-04-22 | 济南高达信息技术有限公司 | Traditional Chinese medicine decoction for treating pancreatic pseudocyst |
| CN105709139A (en) * | 2014-12-25 | 2016-06-29 | 晏合桢 | Medicine for treating tumor and cancer |
| CN109745499A (en) * | 2017-11-02 | 2019-05-14 | 胡志安 | A kind of Chinese herbal medicine pill that treating lympha tumour and preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1188153C (en) | 2005-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1695694A (en) | Chinese traditional medicine for treating breast disease and preparing technique | |
| CN100528211C (en) | Traditional Chinese medicine for treating tumor | |
| CN103127422B (en) | Medicament for treating ulcerative colitis | |
| CN1814208A (en) | Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis | |
| CN1183919C (en) | Cancer treating medical composition | |
| CN1188153C (en) | Medicines for treating cancers and tumours | |
| CN102688317A (en) | Traditional Chinese medicine for treating liver cancer | |
| CN1058620C (en) | Yingfengaidi medicine and its production process | |
| CN1883640A (en) | Medicine for treating leucocytopenia caused after tumor radiotherapy and chemotherapy | |
| CN102764315B (en) | Medicine for treating goiter | |
| CN1168475C (en) | Chinese herbal medicine composition for treating pyloric spirobacterium infected gastropathy and its production process | |
| CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN1054541C (en) | Traditional Chinese medicine for treating mastosis | |
| CN1285354C (en) | Medicine for treating cerebral infarction | |
| CN102940765A (en) | Medicine for treating breast cancer and preparation method of medicine | |
| CN1169555C (en) | A Chinese medicinal decoction pill for treating hepatitis B | |
| CN1157219C (en) | Medicine for treating cancer | |
| CN101057945A (en) | Traditional Chinese medicine for treating digestive cancer and its producing method | |
| CN101513508A (en) | Chinese medicament for treating breast cancer, and preparation method thereof | |
| CN1857630A (en) | Proteinuria treating Chinese medicine and its preparing method and use | |
| CN1313107C (en) | Medicine for treating tumor | |
| CN1140071A (en) | Anticancer drug and preparing method thereof | |
| CN1836702A (en) | Medicine for treating tumour and its preparing method | |
| CN1114885A (en) | External-use medicine powder for health care, nourishing kidney and clearing brain | |
| CN1256976C (en) | Anti-cancer Chinese medicinal composition and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050209 Termination date: 20111226 |